Trial intelligence / Profile preview

Contraceptive patch SH P00331F vs. a comparator patch

NCT00185354Phase 3Completed

Sponsor
Bayer
Start
Nov 2004
Primary completion
Apr 2006
Modality
Small Molecules
Countries
4
01

Overview

Phase 3, randomised, open-label trial of ethinyl estradiol + gestodene in contraception (2 arms), sponsored by Bayer. Primary endpoints: Bleeding pattern and cycle control and Number of pregnancies. Started Nov 2004; status: completed.

02

Drugs

ethinyl estradiol + gestodene
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00185354.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00185354.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call